Fiona Yull

Last active: 3/31/2020


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Optimizing Mannose "Click" Conjugation to Polymeric Nanoparticles for Targeted siRNA Delivery to Human and Murine Macrophages. Glass EB, Masjedi S, Dudzinski SO, Wilson AJ, Duvall CL, Yull FE, Giorgio TD (2019) ACS Omega 4(16): 16756-16767
    › Primary publication · 31646220 (PubMed) · PMC6796989 (PubMed Central)
  2. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy. Gupta V, Yull F, Khabele D (2018) Cancers (Basel) 10(10)
    › Primary publication · 30274280 (PubMed) · PMC6210537 (PubMed Central)
  3. Immunity drives regulation in cancer through NF-κB. Collignon E, Canale A, Al Wardi C, Bizet M, Calonne E, Dedeurwaerder S, Garaud S, Naveaux C, Barham W, Wilson A, Bouchat S, Hubert P, Van Lint C, Yull F, Sotiriou C, Willard-Gallo K, Noel A, Fuks F (2018) Sci Adv 4(6): eaap7309
    › Primary publication · 29938218 (PubMed) · PMC6010319 (PubMed Central)
  4. p52 expression enhances lung cancer progression. Saxon JA, Yu H, Polosukhin VV, Stathopoulos GT, Gleaves LA, McLoed AG, Massion PP, Yull FE, Zhao Z, Blackwell TS (2018) Sci Rep 8(1): 6078
    › Primary publication · 29666445 (PubMed) · PMC5904214 (PubMed Central)
  5. IκB Kinase α Is Required for Development and Progression of -Mutant Lung Adenocarcinoma. Vreka M, Lilis I, Papageorgopoulou M, Giotopoulou GA, Lianou M, Giopanou I, Kanellakis NI, Spella M, Agalioti T, Armenis V, Goldmann T, Marwitz S, Yull FE, Blackwell TS, Pasparakis M, Marazioti A, Stathopoulos GT (2018) Cancer Res 78(11): 2939-2951
    › Primary publication · 29588349 (PubMed) · PMC6485619 (PubMed Central)
  6. Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment. Saxon JA, Sherrill TP, Polosukhin VV, Sai J, Zaynagetdinov R, McLoed AG, Gulleman PM, Barham W, Cheng DS, Hunt RP, Gleaves LA, Richmond A, Young LR, Yull FE, Blackwell TS (2016) Oncoimmunology 5(6): e1168549
    › Primary publication · 27471643 (PubMed) · PMC4938365 (PubMed Central)
  7. Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer. McLoed AG, Sherrill TP, Cheng DS, Han W, Saxon JA, Gleaves LA, Wu P, Polosukhin VV, Karin M, Yull FE, Stathopoulos GT, Georgoulias V, Zaynagetdinov R, Blackwell TS (2016) Cell Rep 16(1): 120-132
    › Primary publication · 27320908 (PubMed) · PMC4927403 (PubMed Central)
  8. Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions. Ortega RA, Barham W, Sharman K, Tikhomirov O, Giorgio TD, Yull FE (2016) Int J Nanomedicine : 2163-77
    › Primary publication · 27274241 (PubMed) · PMC4876941 (PubMed Central)
  9. IL-1β and Inflammasome Activity Link Inflammation to Abnormal Fetal Airway Development. Stouch AN, McCoy AM, Greer RM, Lakhdari O, Yull FE, Blackwell TS, Hoffman HM, Prince LS (2016) J Immunol 196(8): 3411-20
    › Primary publication · 26951798 (PubMed) · PMC5315059 (PubMed Central)
  10. Activation of NF-κB drives the enhanced survival of adipose tissue macrophages in an obesogenic environment. Hill AA, Anderson-Baucum EK, Kennedy AJ, Webb CD, Yull FE, Hasty AH (2015) Mol Metab 4(10): 665-77
    › Primary publication · 26779432 (PubMed) · PMC4588436 (PubMed Central)
  11. p52 Overexpression Increases Epithelial Apoptosis, Enhances Lung Injury, and Reduces Survival after Lipopolysaccharide Treatment. Saxon JA, Cheng DS, Han W, Polosukhin VV, McLoed AG, Richmond BW, Gleaves LA, Tanjore H, Sherrill TP, Barham W, Yull FE, Blackwell TS (2016) J Immunol 196(4): 1891-9
    › Primary publication · 26773153 (PubMed) · PMC4744539 (PubMed Central)
  12. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer. Wilson AJ, Saskowski J, Barham W, Khabele D, Yull F (2015) Mol Cancer : 192
    › Primary publication · 26552746 (PubMed) · PMC4640396 (PubMed Central)
  13. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. Barham W, Chen L, Tikhomirov O, Onishko H, Gleaves L, Stricker TP, Blackwell TS, Yull FE (2015) BMC Cancer : 647
    › Primary publication · 26424146 (PubMed) · PMC4590702 (PubMed Central)
  14. NF-κB-dependent airway inflammation triggers systemic insulin resistance. Cyphert TJ, Morris RT, House LM, Barnes TM, Otero YF, Barham WJ, Hunt RP, Zaynagetdinov R, Yull FE, Blackwell TS, McGuinness OP (2015) Am J Physiol Regul Integr Comp Physiol 309(9): R1144-52
    › Primary publication · 26377563 (PubMed) · PMC4666958 (PubMed Central)
  15. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer. Wilson AJ, Saskowski J, Barham W, Yull F, Khabele D (2015) J Ovarian Res : 46
    › Primary publication · 26215403 (PubMed) · PMC4517540 (PubMed Central)
  16. Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment. Zaynagetdinov R, Sherrill TP, Gleaves LA, McLoed AG, Saxon JA, Habermann AC, Connelly L, Dulek D, Peebles RS, Fingleton B, Yull FE, Stathopoulos GT, Blackwell TS (2015) Cancer Res 75(8): 1624-1634
    › Primary publication · 25691457 (PubMed) · PMC4401663 (PubMed Central)
  17. Evidence for a novel functional role of astrocytes in the acute homeostatic response to high-fat diet intake in mice. Buckman LB, Thompson MM, Lippert RN, Blackwell TS, Yull FE, Ellacott KL (2015) Mol Metab 4(1): 58-63
    › Primary publication · 25685690 (PubMed) · PMC4314532 (PubMed Central)
  18. Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages. Ortega RA, Barham WJ, Kumar B, Tikhomirov O, McFadden ID, Yull FE, Giorgio TD (2015) Nanoscale 7(2): 500-10
    › Primary publication · 25408159 (PubMed)
  19. Molecular imaging of folate receptor β-positive macrophages during acute lung inflammation. Han W, Zaynagetdinov R, Yull FE, Polosukhin VV, Gleaves LA, Tanjore H, Young LR, Peterson TE, Manning HC, Prince LS, Blackwell TS (2015) Am J Respir Cell Mol Biol 53(1): 50-9
    › Primary publication · 25375039 (PubMed) · PMC4566110 (PubMed Central)
  20. Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response. Yang J, Hawkins OE, Barham W, Gilchuk P, Boothby M, Ayers GD, Joyce S, Karin M, Yull FE, Richmond A (2014) Cancer Res 74(24): 7274-84
    › Primary publication · 25336190 (PubMed) · PMC4349570 (PubMed Central)
  21. IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm. Stouch AN, Zaynagetdinov R, Barham WJ, Stinnett AM, Slaughter JC, Yull FE, Hoffman HM, Blackwell TS, Prince LS (2014) J Immunol 193(3): 1184-93
    › Primary publication · 24981452 (PubMed) · PMC4108541 (PubMed Central)
  22. NF-κB gene signature predicts prostate cancer progression. Jin R, Yi Y, Yull FE, Blackwell TS, Clark PE, Koyama T, Smith JA, Matusik RJ (2014) Cancer Res 74(10): 2763-72
    › Primary publication · 24686169 (PubMed) · PMC4024337 (PubMed Central)
  23. Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. Shi C, Washington MK, Chaturvedi R, Drosos Y, Revetta FL, Weaver CJ, Buzhardt E, Yull FE, Blackwell TS, Sosa-Pineda B, Whitehead RH, Beauchamp RD, Wilson KT, Means AL (2014) Lab Invest 94(4): 409-21
    › Primary publication · 24535260 (PubMed) · PMC3992484 (PubMed Central)
  24. NF-κB inhibition after cecal ligation and puncture reduces sepsis-associated lung injury without altering bacterial host defense. Li H, Han W, Polosukhin V, Yull FE, Segal BH, Xie CM, Blackwell TS (2013) Mediators Inflamm : 503213
    › Primary publication · 24347827 (PubMed) · PMC3852536 (PubMed Central)
  25. Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model. Wilson AJ, Barham W, Saskowski J, Tikhomirov O, Chen L, Lee HJ, Yull F, Khabele D (2013) J Ovarian Res 6(1): 63
    › Primary publication · 24020521 (PubMed) · PMC3846584 (PubMed Central)
  26. Targeting the Wnt pathway in synovial sarcoma models. Barham W, Frump AL, Sherrill TP, Garcia CB, Saito-Diaz K, VanSaun MN, Fingleton B, Gleaves L, Orton D, Capecchi MR, Blackwell TS, Lee E, Yull F, Eid JE (2013) Cancer Discov 3(11): 1286-301
    › Primary publication · 23921231 (PubMed) · PMC3823757 (PubMed Central)
  27. Increased dietary sodium induces COX2 expression by activating NFκB in renal medullary interstitial cells. He W, Zhang M, Zhao M, Davis LS, Blackwell TS, Yull F, Breyer MD, Hao CM (2014) Pflugers Arch 466(2): 357-367
    › Primary publication · 23900806 (PubMed) · PMC3946848 (PubMed Central)
  28. NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity. Han W, Li H, Cai J, Gleaves LA, Polosukhin VV, Segal BH, Yull FE, Blackwell TS (2013) J Immunol 190(9): 4786-94
    › Primary publication · 23530143 (PubMed) · PMC3633681 (PubMed Central)
  29. Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles. Yu SS, Lau CM, Barham WJ, Onishko HM, Nelson CE, Li H, Smith CA, Yull FE, Duvall CL, Giorgio TD (2013) Mol Pharm 10(3): 975-87
    › Primary publication · 23331322 (PubMed) · PMC3595119 (PubMed Central)
  30. Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling. Edwards JR, Perrien DS, Fleming N, Nyman JS, Ono K, Connelly L, Moore MM, Lwin ST, Yull FE, Mundy GR, Elefteriou F (2013) J Bone Miner Res 28(4): 960-9
    › Primary publication · 23172686 (PubMed)
  31. Intraductal injection of LPS as a mouse model of mastitis: signaling visualized via an NF-κB reporter transgenic. Barham W, Sherrill T, Connelly L, Blackwell TS, Yull FE (2012) J Vis Exp (67): e4030
    › Primary publication · 22971993 (PubMed) · PMC3490260 (PubMed Central)
  32. Mother-daughter communication about breast cancer risk: interpersonal and biological stress processes. Berlin KL, Andreotti C, Yull F, Grau AM, Compas BE (2013) J Behav Med 36(3): 328-39
    › Primary publication · 22569774 (PubMed)
  33. Tumor microenvironment complexity: emerging roles in cancer therapy. Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, Coussens LM, DeClerck YA (2012) Cancer Res 72(10): 2473-80
    › Primary publication · 22414581 (PubMed) · PMC3653596 (PubMed Central)
  34. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Arima Y, Harada M, Kamimura D, Park JH, Kawano F, Yull FE, Kawamoto T, Iwakura Y, Betz UA, Márquez G, Blackwell TS, Ohira Y, Hirano T, Murakami M (2012) Cell 148(3): 447-57
    › Primary publication · 22304915 (PubMed)
  35. Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis. Karabela SP, Psallidas I, Sherrill TP, Kairi CA, Zaynagetdinov R, Cheng DS, Vassiliou S, McMahon F, Gleaves LA, Han W, Stathopoulos I, Zakynthinos SG, Yull FE, Roussos C, Kalomenidis I, Blackwell TS, Stathopoulos GT (2012) Carcinogenesis 33(4): 859-67
    › Primary publication · 22287559 (PubMed) · PMC3324442 (PubMed Central)
  36. A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. Zaynagetdinov R, Sherrill TP, Polosukhin VV, Han W, Ausborn JA, McLoed AG, McMahon FB, Gleaves LA, Degryse AL, Stathopoulos GT, Yull FE, Blackwell TS (2011) J Immunol 187(11): 5703-11
    › Primary publication · 22048774 (PubMed) · PMC3221921 (PubMed Central)
  37. Epithelial nuclear factor-κB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes. Zaynagetdinov R, Stathopoulos GT, Sherrill TP, Cheng DS, McLoed AG, Ausborn JA, Polosukhin VV, Connelly L, Zhou W, Fingleton B, Peebles RS, Prince LS, Yull FE, Blackwell TS (2012) Oncogene 31(26): 3164-76
    › Primary publication · 22002309 (PubMed) · PMC3266969 (PubMed Central)
  38. NF-κB inducing kinase, NIK mediates cigarette smoke/TNFα-induced histone acetylation and inflammation through differential activation of IKKs. Chung S, Sundar IK, Hwang JW, Yull FE, Blackwell TS, Kinnula VL, Bulger M, Yao H, Rahman I (2011) PLoS One 6(8): e23488
    › Primary publication · 21887257 (PubMed) · PMC3160853 (PubMed Central)
  39. NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model. Connelly L, Barham W, Onishko HM, Chen L, Sherrill TP, Zabuawala T, Ostrowski MC, Blackwell TS, Yull FE (2011) Breast Cancer Res 13(4): R83
    › Primary publication · 21884585 (PubMed) · PMC3236346 (PubMed Central)
  40. Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts. Chen AC, Arany PR, Huang YY, Tomkinson EM, Sharma SK, Kharkwal GB, Saleem T, Mooney D, Yull FE, Blackwell TS, Hamblin MR (2011) PLoS One 6(7): e22453
    › Primary publication · 21814580 (PubMed) · PMC3141042 (PubMed Central)
  41. NF-κB signaling in fetal lung macrophages disrupts airway morphogenesis. Blackwell TS, Hipps AN, Yamamoto Y, Han W, Barham WJ, Ostrowski MC, Yull FE, Prince LS (2011) J Immunol 187(5): 2740-7
    › Primary publication · 21775686 (PubMed) · PMC3159744 (PubMed Central)
  42. Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs. Lawson WE, Cheng DS, Degryse AL, Tanjore H, Polosukhin VV, Xu XC, Newcomb DC, Jones BR, Roldan J, Lane KB, Morrisey EE, Beers MF, Yull FE, Blackwell TS (2011) Proc Natl Acad Sci U S A 108(26): 10562-7
    › Primary publication · 21670280 (PubMed) · PMC3127925 (PubMed Central)
  43. Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, Blackwell TS, Yull FE (2011) Oncogene 30(12): 1402-12
    › Primary publication · 21076466 (PubMed) · PMC3063854 (PubMed Central)
  44. Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion. Stathopoulos GT, Sherrill TP, Karabela SP, Goleniewska K, Kalomenidis I, Roussos C, Fingleton B, Yull FE, Peebles RS, Blackwell TS (2010) Am J Respir Crit Care Med 182(10): 1273-81
    › Primary publication · 20595227 (PubMed) · PMC3001265 (PubMed Central)
  45. Conditional ablation of Ikkb inhibits melanoma tumor development in mice. Yang J, Splittgerber R, Yull FE, Kantrow S, Ayers GD, Karin M, Richmond A (2010) J Clin Invest 120(7): 2563-74
    › Primary publication · 20530876 (PubMed) · PMC2898608 (PubMed Central)
  46. NADPH oxidase limits innate immune responses in the lungs in mice. Segal BH, Han W, Bushey JJ, Joo M, Bhatti Z, Feminella J, Dennis CG, Vethanayagam RR, Yull FE, Capitano M, Wallace PK, Minderman H, Christman JW, Sporn MB, Chan J, Vinh DC, Holland SM, Romani LR, Gaffen SL, Freeman ML, Blackwell TS (2010) PLoS One 5(3): e9631
    › Primary publication · 20300512 (PubMed) · PMC2838778 (PubMed Central)
  47. Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection. Connelly L, Barham W, Pigg R, Saint-Jean L, Sherrill T, Cheng DS, Chodosh LA, Blackwell TS, Yull FE (2010) J Cell Physiol 222(1): 73-81
    › Primary publication · 19746431 (PubMed) · PMC2783968 (PubMed Central)
  48. The protein kinase IKKepsilon regulates energy balance in obese mice. Chiang SH, Bazuine M, Lumeng CN, Geletka LM, Mowers J, White NM, Ma JT, Zhou J, Qi N, Westcott D, Delproposto JB, Blackwell TS, Yull FE, Saltiel AR (2009) Cell 138(5): 961-75
    › Primary publication · 19737522 (PubMed) · PMC2756060 (PubMed Central)
  49. Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. Singh MV, Kapoun A, Higgins L, Kutschke W, Thurman JM, Zhang R, Singh M, Yang J, Guan X, Lowe JS, Weiss RM, Zimmermann K, Yull FE, Blackwell TS, Mohler PJ, Anderson ME (2009) J Clin Invest 119(4): 986-96
    › Primary publication · 19273909 (PubMed) · PMC2662543 (PubMed Central)
  50. Myeloid cells control termination of lung inflammation through the NF-kappaB pathway. Han W, Joo M, Everhart MB, Christman JW, Yull FE, Blackwell TS (2009) Am J Physiol Lung Cell Mol Physiol 296(3): L320-7
    › Primary publication · 19098124 (PubMed) · PMC2660215 (PubMed Central)
  51. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Saint Jean L, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ (2008) Cancer Res 68(16): 6762-9
    › Primary publication · 18701501 (PubMed) · PMC2840631 (PubMed Central)
  52. The nuclear factor kappa-B pathway in airway epithelium regulates neutrophil recruitment and host defence following Pseudomonas aeruginosa infection. Chen SM, Cheng DS, Williams BJ, Sherrill TP, Han W, Chont M, Saint-Jean L, Christman JW, Sadikot RT, Yull FE, Blackwell TS (2008) Clin Exp Immunol 153(3): 420-8
    › Primary publication · 18647324 (PubMed) · PMC2527362 (PubMed Central)
  53. Host nuclear factor-kappaB activation potentiates lung cancer metastasis. Stathopoulos GT, Sherrill TP, Han W, Sadikot RT, Yull FE, Blackwell TS, Fingleton B (2008) Mol Cancer Res 6(3): 364-71
    › Primary publication · 18337446 (PubMed)
  54. Use of bioluminescent imaging to investigate the role of nuclear factor-kappaBeta in experimental non-small cell lung cancer metastasis. Stathopoulos GT, Sherrill TP, Han W, Sadikot RT, Polosukhin VV, Fingleton B, Yull FE, Blackwell TS (2008) Clin Exp Metastasis 25(1): 43-51
    › Primary publication · 18008176 (PubMed)
  55. Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Stathopoulos GT, Sherrill TP, Cheng DS, Scoggins RM, Han W, Polosukhin VV, Connelly L, Yull FE, Fingleton B, Blackwell TS (2007) Proc Natl Acad Sci U S A 104(47): 18514-9
    › Primary publication · 18000061 (PubMed) · PMC2141808 (PubMed Central)
  56. Conditional regulation of cyclooxygenase-2 in tracheobronchial epithelial cells modulates pulmonary immunity. Park GY, Hu N, Wang X, Sadikot RT, Yull FE, Joo M, Peebles RS, Blackwell TS, Christman JW (2007) Clin Exp Immunol 150(2): 245-54
    › Primary publication · 17672868 (PubMed) · PMC2219354 (PubMed Central)
  57. Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. Cheng DS, Han W, Chen SM, Sherrill TP, Chont M, Park GY, Sheller JR, Polosukhin VV, Christman JW, Yull FE, Blackwell TS (2007) J Immunol 178(10): 6504-13
    › Primary publication · 17475880 (PubMed)
  58. A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis. Connelly L, Robinson-Benion C, Chont M, Saint-Jean L, Li H, Polosukhin VV, Blackwell TS, Yull FE (2007) J Biol Chem 282(13): 10028-10035
    › Primary publication · 17261585 (PubMed)
  59. Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. Everhart MB, Han W, Sherrill TP, Arutiunov M, Polosukhin VV, Burke JR, Sadikot RT, Christman JW, Yull FE, Blackwell TS (2006) J Immunol 176(8): 4995-5005
    › Primary publication · 16585596 (PubMed)
  60. Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. Sadikot RT, Zeng H, Joo M, Everhart MB, Sherrill TP, Li B, Cheng DS, Yull FE, Christman JW, Blackwell TS (2006) J Immunol 176(8): 4923-30
    › Primary publication · 16585588 (PubMed)
  61. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. Stafforini DM, Sheller JR, Blackwell TS, Sapirstein A, Yull FE, McIntyre TM, Bonventre JV, Prescott SM, Roberts LJ (2006) J Biol Chem 281(8): 4616-23
    › Primary publication · 16371369 (PubMed)
  62. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. Stathopoulos GT, Zhu Z, Everhart MB, Kalomenidis I, Lawson WE, Bilaceroglu S, Peterson TE, Mitchell D, Yull FE, Light RW, Blackwell TS (2006) Am J Respir Cell Mol Biol 34(2): 142-50
    › Primary publication · 16210694 (PubMed) · PMC2644178 (PubMed Central)
  63. Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. O'Donnell SM, Hansberger MW, Connolly JL, Chappell JD, Watson MJ, Pierce JM, Wetzel JD, Han W, Barton ES, Forrest JC, Valyi-Nagy T, Yull FE, Blackwell TS, Rottman JN, Sherry B, Dermody TS (2005) J Clin Invest 115(9): 2341-50
    › Primary publication · 16100570 (PubMed) · PMC1184036 (PubMed Central)
  64. Intratracheal administration of liposomal clodronate accelerates alveolar macrophage reconstitution following fetal liver transplantation. Everhart MB, Han W, Parman KS, Polosukhin VV, Zeng H, Sadikot RT, Li B, Yull FE, Christman JW, Blackwell TS (2005) J Leukoc Biol 77(2): 173-80
    › Primary publication · 15563581 (PubMed)
  65. Inhaled isobutyl nitrite inhibited macrophage inducible nitric oxide by blocking NFkappaB signaling and promoting degradation of inducible nitric oxide synthase-2. Ponnappan U, Yull FE, Soderberg LS (2004) Int Immunopharmacol 4(8): 1075-82
    › Primary publication · 15222982 (PubMed)
  66. Upregulation of 8-lipoxygenase in the dermatitis of IkappaB-alpha-deficient mice. Schneider C, Strayhorn WD, Brantley DM, Nanney LB, Yull FE, Brash AR (2004) J Invest Dermatol 122(3): 691-8
    › Primary publication · 15086555 (PubMed)
  67. p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. Sadikot RT, Zeng H, Yull FE, Li B, Cheng DS, Kernodle DS, Jansen ED, Contag CH, Segal BH, Holland SM, Blackwell TS, Christman JW (2004) J Immunol 172(3): 1801-8
    › Primary publication · 14734763 (PubMed)
  68. Bioluminescent detection of endotoxin effects on HIV-1 LTR-driven transcription in vivo. Yull FE, Han W, Jansen ED, Everhart MB, Sadikot RT, Christman JW, Blackwell TS (2003) J Histochem Cytochem 51(6): 741-9
    › Primary publication · 12754285 (PubMed)
  69. Systemic nf-kappaB activation in a transgenic mouse model of acute pancreatitis. Gray KD, Simovic MO, Chapman WC, Blackwell TS, Christman JW, Washington MK, Yull FE, Jaffal N, Jansen ED, Gautman S, Stain SC (2003) J Surg Res 110(1): 310-4
    › Primary publication · 12697416 (PubMed)
  70. Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation. Sadikot RT, Han W, Everhart MB, Zoia O, Peebles RS, Jansen ED, Yull FE, Christman JW, Blackwell TS (2003) J Immunol 170(2): 1091-8
    › Primary publication · 12517978 (PubMed)
  71. Hepatic cryoablation-induced multisystem injury: bioluminescent detection of NF-kappaB activation in a transgenic mouse model. Sadikot RT, Wudel LJ, Jansen DE, Debelak JP, Yull FE, Christman JW, Blackwell TS, Chapman WC (2002) J Gastrointest Surg 6(2): 264-70
    › Primary publication · 11992813 (PubMed)
  72. High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice. Sadikot RT, Jansen ED, Blackwell TR, Zoia O, Yull F, Christman JW, Blackwell TS (2001) Am J Respir Crit Care Med 164(5): 873-8
    › Primary publication · 11549548 (PubMed)
  73. NF-kappaB mediates FGF signal regulation of msx-1 expression. Bushdid PB, Chen CL, Brantley DM, Yull F, Raghow R, Kerr LD, Barnett JV (2001) Dev Biol 237(1): 107-15
    › Primary publication · 11518509 (PubMed)
  74. Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Brantley DM, Chen CL, Muraoka RS, Bushdid PB, Bradberry JL, Kittrell F, Medina D, Matrisian LM, Kerr LD, Yull FE (2001) Mol Biol Cell 12(5): 1445-55
    › Primary publication · 11359934 (PubMed) · PMC34596 (PubMed Central)
  75. RAG2-/-, I kappa B-alpha-/- chimeras display a psoriasiform skin disease. Chen CL, Yull FE, Cardwell N, Singh N, Strayhorn WD, Nanney LB, Kerr LD (2000) J Invest Dermatol 115(6): 1124-33
    › Primary publication · 11121151 (PubMed)
  76. Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function. Chen CL, Singh N, Yull FE, Strayhorn D, Van Kaer L, Kerr LD (2000) J Immunol 165(10): 5418-27
    › Primary publication · 11067893 (PubMed)
  77. Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. Hao CM, Yull F, Blackwell T, Kömhoff M, Davis LS, Breyer MD (2000) J Clin Invest 106(8): 973-82
    › Primary publication · 11032857 (PubMed) · PMC314340 (PubMed Central)
  78. Dynamic expression and activity of NF-kappaB during post-natal mammary gland morphogenesis. Brantley DM, Yull FE, Muraoka RS, Hicks DJ, Cook CM, Kerr LD (2000) Mech Dev 97(1-2): 149-55
    › Primary publication · 11025216 (PubMed)
  79. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Blackwell TS, Yull FE, Chen CL, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD (2000) Am J Respir Crit Care Med 162(3 Pt 1): 1095-101
    › Primary publication · 10988136 (PubMed)
  80. Mesenchymal expression of nuclear factor-kappaB inhibits epithelial growth and branching in the embryonic chick lung. Muraoka RS, Bushdid PB, Brantley DM, Yull FE, Kerr LD (2000) Dev Biol 225(2): 322-38
    › Primary publication · 10985853 (PubMed)
  81. Nuclear factor-kappaB/Rel is apoptogenic in cytokine withdrawal-induced programmed cell death. Sohur US, Chen CL, Hicks DJ, Yull FE, Kerr LD (2000) Cancer Res 60(5): 1202-5
    › Primary publication · 10728675 (PubMed)
  82. Use of genetically altered mice to investigate the role of nuclear factor-kappa B activation and cytokine gene expression in sepsis-induced ARDS. Blackwell TS, Yull FE, Chen CL, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD (1999) Chest 116(1 Suppl): 73S-74S
    › Primary publication · 10424600 (PubMed)
  83. Differential serine phosphorylation regulates IkappaB-alpha inactivation. Chen CL, Yull FE, Kerr LD (1999) Biochem Biophys Res Commun 257(3): 798-806
    › Primary publication · 10208863 (PubMed)
  84. Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Bushdid PB, Brantley DM, Yull FE, Blaeuer GL, Hoffman LH, Niswander L, Kerr LD (1998) Nature 392(6676): 615-8
    › Primary publication · 9560159 (PubMed)
  85. Selective cell ablation in transgenic mice expression E. coli nitroreductase. Clark AJ, Iwobi M, Cui W, Crompton M, Harold G, Hobbs S, Kamalati T, Knox R, Neil C, Yull F, Gusterson B (1997) Gene Ther 4(2): 101-10
    › Primary publication · 9081700 (PubMed)
  86. Transgene rescue in the mammary gland is associated with transcription but does not require translation of BLG transgenes. Yull F, Binas B, Harold G, Wallace R, Clark AJ (1997) Transgenic Res 6(1): 11-7
    › Primary publication · 9032973 (PubMed)
  87. Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice. Clark AJ, Harold G, Yull FE (1997) Nucleic Acids Res 25(5): 1009-14
    › Primary publication · 9023112 (PubMed) · PMC146529 (PubMed Central)
  88. Restricted tissue-specific but correct developmental expression mediated by a short human alpha 1AT promoter fragment in transgenic mice. Yull FE, Wallace RM, Clark AJ (1995) Transgenic Res 4(1): 70-4
    › Primary publication · 7881464 (PubMed)
  89. Chromosomal position effects and the modulation of transgene expression. Clark AJ, Bissinger P, Bullock DW, Damak S, Wallace R, Whitelaw CB, Yull F (1994) Reprod Fertil Dev 6(5): 589-98
    › Primary publication · 7569038 (PubMed)
  90. Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice. Yull F, Harold G, Wallace R, Cowper A, Percy J, Cottingham I, Clark AJ (1995) Proc Natl Acad Sci U S A 92(24): 10899-903
    › Primary publication · 7479906 (PubMed) · PMC40538 (PubMed Central)
  91. Reconstruction of the yeast 2 micron plasmid partitioning mechanism. Dobson MJ, Yull FE, Molina M, Kingsman SM, Kingsman AJ (1988) Nucleic Acids Res 16(14B): 7103-17
    › Primary publication · 3043377 (PubMed) · PMC338354 (PubMed Central)